SemperSan Overview

  • Status
  • Out of Business

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Out of Business

SemperSan General Information

Description

Developer of a peptide intended to serve as an alternative sugar for diabetic patients. The company develops a food ingredient from whey which there is a positive effect on patients suffering from type 2 diabetes, enabling patients to have access to drugs that address and help stabilize diabetes.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • Am Hof 5/11
  • Vienna, 1010
  • Austria
+43 01
Primary Industry
Pharmaceuticals
Corporate Office
  • Am Hof 5/11
  • Vienna, 1010
  • Austria
+43 01

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SemperSan Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 29-Jun-2022 Completed Out of Business
1. Accelerator/Incubator Completed Generating Revenue
To view SemperSan’s complete valuation and funding history, request access »

SemperSan Patents

SemperSan Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
DE-102006036285-A1 Whey permeate fractions and their use for the prevention and treatment of type 2 diabetes and metabolic syndrome Inactive 03-Aug-2006
US-9877995-B2 Fractions of whey permeate and use thereof for the prevention and therapy of type 2 diabetes and the metabolic syndrome Active 03-Aug-2006
US-20090274768-A1 Fraktionen aus molkepermeat und deren verwendung zur pravention und therapie des typ-2 diabetes und des metabolischen syndroms Active 03-Aug-2006
ES-2531085-T3 Fractions of whey permeate and its use for the prevention and therapy of type 2 diabetes and metabolic syndrome Active 03-Aug-2006
EP-2048969-B1 Fractions of whey permeate and its use for the prevention and therapy of type 2 diabetes and the metabolic syndrome Active 03-Aug-2006 A61K38/018
To view SemperSan’s complete patent history, request access »

SemperSan Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SemperSan FAQs

  • Where is SemperSan headquartered?

    SemperSan is headquartered in Vienna, Austria.

  • What is the size of SemperSan?

    SemperSan has 3 total employees.

  • What industry is SemperSan in?

    SemperSan’s primary industry is Pharmaceuticals.

  • Is SemperSan a private or public company?

    SemperSan is a Private company.

  • What is SemperSan’s current revenue?

    The current revenue for SemperSan is .

  • How much funding has SemperSan raised over time?

    SemperSan has raised $35.6K.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »